title: Diphenyl diselenide protects against glycerol-induced renal damage in rats.
abstract: In this study we evaluated the effect of diphenyl diselenide (PhSe)(2) on glycerol-induced acute renal failure in rats. Rats were pre-treated by gavage every day with (PhSe)(2 )(7.14 mg kg(-1)) for 7 days. On the eighth day, rats received an intramuscular injection of glycerol (8 mL kg(-1)). Twenty-four hours afterwards, rats were euthanized and the levels of urea and creatinine were measured in plasma. Catalase (CAT), glutathione peroxidase (GPx), glutathione S-transferase (GST), delta-aminolevulinate dehydratase (delta-ALA-D) and Na(+), K(+)-ATPase activities and ascorbic acid levels were evaluated in renal homogenates. Histopathological evaluations were also performed. The results demonstrated that (PhSe)(2) was able to protect against the increase in urea and creatinine levels and histological alterations in kidney induced by glycerol. (PhSe)(2) protected against the inhibition in delta-ALA-D, CAT and GPx activities and the reduction in ascorbic acid levels induced by glycerol in kidneys of rats. In conclusion, the present results indicate that (PhSe)(2) was effective in protecting against acute renal failure induced by glycerol.
authors.forename: Ricardo
authors.initials: R
authors.lastname: Brandão
authors.forename: Carmine I
authors.initials: CI
authors.lastname: Acker
authors.forename: Marlon R
authors.initials: MR
authors.lastname: Leite
authors.forename: Nilda B V
authors.initials: NB
authors.lastname: Barbosa
authors.forename: Cristina W
authors.initials: CW
authors.lastname: Nogueira
mesh_terms: D000818:Animals; D001205:Ascorbic Acid / Q000032:analysis / Q000378:metabolism; D001555:Benzene Derivatives / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D002374:Catalase / Q000378:metabolism; D003404:Creatinine / Q000097:blood; D004347:Drug Interactions; D005979:Glutathione Peroxidase / Q000378:metabolism; D005982:Glutathione Transferase / Q000378:metabolism; D005990:Glycerol / Q000494:pharmacology*; D007668:Kidney / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008297:Male; D016566:Organoselenium Compounds / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D018384:Oxidative Stress / Q000187:drug effects; D000623:Porphobilinogen Synthase / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D000254:Sodium-Potassium-Exchanging ATPase / Q000378:metabolism; D014508:Urea / Q000097:blood
chemical_list: D001555:Benzene Derivatives; D016566:Organoselenium Compounds; C061132:diphenyldiselenide; D014508:Urea; D003404:Creatinine; D002374:Catalase; D005979:Glutathione Peroxidase; D005982:Glutathione Transferase; D000623:Porphobilinogen Synthase; D000254:Sodium-Potassium-Exchanging ATPase; D005990:Glycerol; D001205:Ascorbic Acid